Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Aug 14;9(8):e104484.
doi: 10.1371/journal.pone.0104484. eCollection 2014.

Lymphocyte Activation Gene-3 (LAG-3) negatively regulates environmentally-induced autoimmunity

Affiliations

Lymphocyte Activation Gene-3 (LAG-3) negatively regulates environmentally-induced autoimmunity

Vibha Jha et al. PLoS One. .

Abstract

Environmental factors including drugs, mineral oils and heavy metals such as lead, gold and mercury are triggers of autoimmune diseases in animal models or even in occupationally exposed humans. After exposure to subtoxic levels of mercury (Hg), genetically susceptible strains of mice develop an autoimmune disease characterized by the production of highly specific anti-nucleolar autoantibodies, hyperglobulinemia and nephritis. However, mice can be tolerized to the disease by a single low dose administration of Hg. Lymphocyte Activation Gene-3 (LAG-3) is a CD4-related, MHC-class II binding molecule expressed on activated T cells and NK cells which maintains lymphocyte homeostatic balance via various inhibitory mechanisms. In our model, administration of anti-LAG-3 monoclonal antibody broke tolerance to Hg resulting in autoantibody production and an increase in serum IgE level. In addition, LAG-3-deficient B6.SJL mice not only had increased susceptibility to Hg-induced autoimmunity but were also unresponsive to tolerance induction. Conversely, adoptive transfer of wild-type CD4(+) T cells was able to partially rescue LAG-3-deficient mice from the autoimmune disease. Further, in LAG-3-deficient mice, mercury elicited higher amounts of IL-6, IL-4 and IFN-γ, cytokines known to play a critical role in mercury-induced autoimmunity. Therefore, we conclude that LAG-3 exerts an important regulatory effect on autoimmunity elicited by a common environmental pollutant.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Exposure to Hg results in higher expression of LAG-3 on CD4+T cells and in an increased amount of soluble LAG-3 in serum.
(A) B6.SJL mice were left untreated or given 3 injections of HgCl2 s.c. on days 0, 2 and 4. Splenocytes were harvested on day 8 and analyzed by flow cytometry. Figure depicts a representative dot plot of total splenocytes gated for LAG-3+ CD4+ T cells. (B) Results are expressed as frequency of LAG-3+ CD4+ T cells in each group (n = 3 or 4). (C) A.SW mice were challenged with 3 injections of HgCl2 (30 µg/mouse) on days 0, 2 and 4. Concentration of soluble LAG-3 (sLAG-3) in serum was measured by ELISA (n = 4 or 5). Unpaired t test was used for statistical analysis where *indicates p<0.05.
Figure 2
Figure 2. LAG-3-deficient B6.SJL mice display an increased susceptibility to mercury-induced autoimmunity.
(A) Wild-type or Lag-3−/− B6.SJL mice were challenged with 3 weekly s.c. injections of 30 µg HgCl2/mouse during four weeks for a total of 12 injections. Serum Ig and autoantibodies were measured as described in the Material and Method section (n = 5 or 6). The levels of Ig depicted at week 0 represent the baseline levels in untreated LAG-3−/− and WT mice whereas the untreated mice in both groups had no detectable autoantibodies. (B) Mice from this experiment were sacrificed after 4 weeks. Their kidney sections were stained with goat anti-mouse IgG-FITC to detect IgG deposits (n = 5). Negative control depicts the staining of kidney section obtained from 3 week old untreated B6.SJL mice. The extent of kidney disease was scored depending on the amount and intensity of IgG staining as described in details in Material and Method section. To determine statistical significance between the groups of fig. 2A and 2B two way ANOVA was used where *indicates p<0.05, **indicates p<0.005 and ***indicates p<0.0001.
Figure 3
Figure 3. A short course of HgCl2 injections is sufficient to induce mercury-induced autoimmunity in LAG-3-deficient B6.SJL mice.
(A) Wild-type or Lag-3−/− B6.SJL mice were challenged with HgCl2 (30 µg/mouse s.c.) on days 0, 2 and 4. Serum was analyzed by ELISA to determine IgG1 and IgE polyclonal antibodies and ANoA titers were measured by IF assay (n = 5 or 6). (B) Kidneys of mice from this experiment were harvested after 4 weeks, sectioned and stained with goat anti-mouse IgG-FITC to detect IgG deposit. The extent of kidney disease was scored depending on the amount and intensity of IgG staining as described in details in Material and Method section. To determine statistical significance between the groups of fig. 2A and 2B two way ANOVA was used where *indicates p<0.05, **indicates p<0.005 and ***indicates p<0.0001.
Figure 4
Figure 4. LAG-3-deficient mice cannot be tolerized to mercury.
Wild-type or LAG-3-deficient mice were given a tolerogenic dose of HgCl2 (3 µg/mouse given i.p.) on day -7. Mice were then exposed to 3 injections of HgCl2 (30 µg/mouse given s.c) on days 0, 2 and 4. Serum Ig were measured by ELISA and ANoA titers were determined by IF assay (n = 5 or 6). To determine statistical significance between the groups two way ANOVA was used where *indicates p<0.05.
Figure 5
Figure 5. Anti-LAG-3 monoclonal antibody breaks established tolerance against mercury-induced autoimmunity.
A.SW mice were tolerized to Hg and 7 days later they received a challenge dose of Hg in conjunction with anti-LAG-3 or control antibody as depicted in the Figure. Serum IgG1 and IgE levels were measured by ELISA and autoantibody titers were determined by IF assay (n = 5). The IgG and IgE concentrations depicted at wk -1 represent the baseline levels of antibodies in serum of untreated mice and no autoantibodies were detectable in untreated mice. To determine statistical significance between the groups two way ANOVA was used where *indicates p<0.05.
Figure 6
Figure 6. LAG-3-deficient mice produce higher amounts of cytokine following mercury treatment.
Wild-type and Lag-3−/− mice were either given a challenge dose of HgCl2 (30 µg/mouse s.c. on days 0, 2 and 4) or were left untreated. Splenocytes were harvested on day 8 and then stimulated in vitro with plate bound anti-CD3 and anti-CD28 antibodies. Supernatant were collected after 72 hrs to determine the levels of cytokine by ELISA (n = 3 or 4). Two way ANOVA was used to determine the statistical significance between the groups where *indicates p<0.05 and ***indicates p<0.0001.
Figure 7
Figure 7. Transfer of wild-type CD4+ T cells decreases autoimmunity in LAG-3-deficient mice.
CD4+ T cells were sorted using FACS and then transferred to LAG-3-deficient mice as depicted in the Figure. Autoantibody titers were measured by IF assay (n = 6). To determine statistical significance between the groups two way ANOVA was used where *indicates p<0.05.

Similar articles

Cited by

References

    1. Schiraldi M, Monestier M (2009) How can a chemical element elicit complex immunopathology? Lessons from mercury-induced autoimmunity. Trends Immunol 30: 502–509. - PubMed
    1. Moszczynski P, Slowinski S, Rutkowski J, Bem S, Jakus-Stoga D (1995) Lymphocytes, T and NK cells, in men occupationally exposed to mercury vapours. Int J Occupational Med Environ Health 8: 49–56. - PubMed
    1. Lauwerys R, Bernard A, Roels H, Buchet JP, Gennart JP, et al. (1983) Anti-laminin antibodies in workers exposed to mercury vapour. Toxicol Letters 17: 113–116. - PubMed
    1. Arnett FC, Reveille JD, Goldstein R, Pollard KM, et al. (1996) Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis. Arthritis Rheum 39: 1151–1160. - PubMed
    1. Silbergeld EK, Silva IA, Nyland JF (2005) Mercury and autoimmunity: implications for occupational and environmental health. Toxicol Appl Pharmacol 207: 282–292. - PubMed

Publication types

MeSH terms